Gender Eligibility Descriptions for Clinical Trials

被引：1
|
作者：
Lee, Tzu-Hao [1 ,3 ]
Streed Jr, Carl G. [2 ]
机构：
[1] Baylor Coll Med, Sect Gastroenterol & Hepatol, Houston, TX USA
[2] Boston Med Ctr, GenderCare Ctr, Boston, MA USA
[3] Baylor Coll Med, Dept Med, Dept Surg, Div Abdominal Transplantat,Sect Gastroenterol & He, 6620 Main St, Ste 1450, Houston, TX 77030 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 331卷 / 16期
关键词：
D O I：
10.1001/jama.2024.0689
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Eligibility criteria in knee osteoarthritis clinical trials: systematic review
    Koog, Yun Hyung
    Wi, Hyungsun
    Jung, Won Young
    CLINICAL RHEUMATOLOGY, 2013, 32 (11) : 1569 - 1574
  • [42] Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
    Apolo, Andrea B.
    Milowsky, Matthew I.
    Kim, Lauren
    Inman, Brant A.
    Kamat, Ashish M.
    Steinberg, Gary
    Bagheri, Mohammadhadi
    Krishnasamy, Venkatesh P.
    Marko, Jamie
    Dinney, Colin P.
    Bangs, Rick
    Sweis, Randy F.
    Maher, Virginia Ellen
    Ibrahim, Amna
    Liu, Ke
    Werntz, Ryan
    Cross, Frank
    Beaver, Julia A.
    Singh, Harpreet
    Pazdur, Richard
    Blumenthal, Gideon M.
    Lerner, Seth P.
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    Agrawal, Sundeep
    JAMA ONCOLOGY, 2019, 5 (12) : 1790 - 1798
  • [43] ASTEC: Automatic selection of clinical trials based on eligibility criteria
    Cuggia, M.
    Dufour, J. -C.
    Zekri, O.
    Gibaud, I.
    Garde, C.
    Bohec, C.
    Duvauferrier, R.
    Fieschi, D.
    Besana, P.
    Charlois, L.
    Bourde, A.
    Garcelon, N.
    Laurent, J.
    Fieschi, M.
    Dameron, O.
    IRBM, 2012, 33 (02) : 150 - 164
  • [44] Trial prospector: An automated clinical trials eligibility matching program
    Parchman, Andrew J.
    Zhang, Guo-Qiang
    Mergler, Patrick
    Barnholtz-Sloan, Jill
    Lanese, Robert
    Miller, Dawn M.
    Opper, Chris
    Sahoo, Satya
    Tao, Shiqiang
    Teagno, Joseph
    Warfe, James
    Meropol, Neal J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Descriptions of non-pharmacological interventions in clinical trials
    Cook, Andrew
    Douet, Lisa
    Boutron, Isabelle
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [46] Eligibility Rates in Axial Spondyloarthritis Clinical Trials Based on Imaging Criteria
    Syed, Farhan A.
    Bennett, David
    O'Connor, Michael
    Pradella, Gabriele
    Warner, Sarah
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [47] Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials
    Oakley, Clayton K.
    Yellala, Amulya
    Tulpule, Sunil
    High, Robin
    Kishor, Apar
    Marr, Alissa S.
    ONCOLOGY-NEW YORK, 2024, 38 (12):
  • [48] Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection
    Mathioudakis, Alexander
    Moberg, Mia
    Janner, Julie
    Alonso-Coello, Pablo
    Vestbo, Jorgen
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [49] Learning Eligibility in Cancer Clinical Trials Using Deep Neural Networks
    Bustos, Aurelia
    Pertusa, Antonio
    APPLIED SCIENCES-BASEL, 2018, 8 (07):
  • [50] Eligibility criteria for phase I clinical trials: tight vs loose?
    Malik, Laeeq
    Lu, David
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 999 - 1002
12345